Predictive	O
value	O
of	O
serum	B-Organism_substance
carbohydrate	O
antigen	O
19	O
-	O
9	O
in	O
malignant	B-Cancer
intraductal	I-Cancer
papillary	I-Cancer
mucinous	I-Cancer
neoplasms	I-Cancer
.	O

BACKGROUND	O
:	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
predictive	O
value	O
of	O
serum	B-Organism_substance
carbohydrate	O
antigen	O
19	O
-	O
9	O
(	O
CA	O
19	O
-	O
9	O
)	O
in	O
the	O
diagnosis	O
of	O
malignant	B-Cancer
intraductal	I-Cancer
papillary	I-Cancer
mucinous	I-Cancer
neoplasms	I-Cancer
of	O
pancreas	B-Organ
(	O
IPMNs	B-Cancer
)	O
.	O

METHODS	O
:	O

Eighty	O
-	O
six	O
patients	O
with	O
pathological	O
diagnosis	O
of	O
IPMNs	B-Cancer
in	O
Zhongshan	O
Hospital	O
between	O
March	O
1999	O
and	O
November	O
2008	O
were	O
retrospectively	O
reviewed	O
.	O

Data	O
reflecting	O
clinical	O
characteristics	O
,	O
tumor	B-Cancer
marker	O
level	O
,	O
and	O
prognosis	O
were	O
collected	O
.	O

The	O
potential	O
predictive	O
value	O
of	O
CA	O
19	O
-	O
9	O
was	O
analyzed	O
by	O
receiver	O
operating	O
characteristic	O
(	O
ROC	O
)	O
curve	O
.	O

RESULTS	O
:	O

Eighty	O
-	O
six	O
consecutive	O
patients	O
with	O
IPMNs	B-Cancer
all	O
underwent	O
surgical	O
intervention	O
.	O

A	O
high	O
level	O
of	O
CA	O
19	O
-	O
9	O
or	O
carcinoembryonic	O
antigen	O
(	O
CEA	O
)	O
was	O
associated	O
with	O
more	O
advanced	O
stage	O
of	O
malignant	B-Cancer
IPMNs	I-Cancer
.	O

Carbohydrate	O
antigen	O
19	O
-	O
9	O
was	O
significant	O
for	O
judging	O
malignant	B-Cancer
IPMNs	I-Cancer
in	O
the	O
binary	O
logistic	O
regression	O
model	O
(	O
p	O
=	O
0	O
.	O
047	O
)	O
.	O

The	O
hazard	O
ratio	O
was	O
1	O
.	O
014	O
,	O
whose	O
95	O
.	O
0	O
%	O
confidence	O
interval	O
was	O
0	O
.	O
91	O
-	O
1	O
.	O
028	O
.	O

Receiver	O
operating	O
characteristic	O
analysis	O
showed	O
that	O
the	O
serum	B-Organism_substance
CA	O
19	O
-	O
9	O
level	O
had	O
good	O
predictive	O
value	O
for	O
malignant	B-Cancer
or	O
invasive	B-Cancer
IPMNs	I-Cancer
,	O
postoperative	O
survival	O
,	O
and	O
disease	O
-	O
specific	O
recurrence	O
.	O

The	O
area	O
under	O
the	O
curve	O
(	O
AUC	O
)	O
was	O
0	O
.	O
856	O
,	O
0	O
.	O
893	O
,	O
0	O
.	O
815	O
,	O
and	O
0	O
.	O
857	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
respectively	O
.	O

According	O
to	O
the	O
follow	O
-	O
up	O
,	O
mean	O
survival	O
time	O
for	O
groups	O
with	O
CA	O
19	O
-	O
9	O
>	O
63	O
.	O
60	O
U	O
/	O
ml	O
was	O
dramatically	O
shorter	O
than	O
that	O
for	O
groups	O
with	O
CA	O
19	O
-	O
9	O
<	O
=	O
63	O
.	O
60	O
U	O
/	O
ml	O
(	O
57	O
.	O
38	O
+	O
/	O
-	O
2	O
.	O
85	O
versus	O
29	O
.	O
24	O
+	O
/	O
-	O
5	O
.	O
82	O
[	O
months	O
]	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

CONCLUSIONS	O
:	O

Serum	B-Organism_substance
CA	O
19	O
-	O
9	O
level	O
has	O
good	O
predictive	O
value	O
for	O
malignant	B-Cancer
or	O
invasive	B-Cancer
IPMNs	I-Cancer
.	O

Patients	O
with	O
CA	O
19	O
-	O
9	O
>	O
63	O
.	O
60	O
U	O
/	O
ml	O
had	O
poor	O
postoperative	O
prognosis	O
in	O
IPMNs	B-Cancer
.	O

Preoperative	O
abnormal	O
serum	B-Organism_substance
CA	O
19	O
-	O
9	O
might	O
be	O
predictive	O
for	O
an	O
aggressive	O
surgical	O
intervention	O
in	O
IPMNs	B-Cancer
.	O

